Dr David Andrews trained as a pharmacist at Nottingham University and then as a PhD organic chemist at Liverpool University. From 1990-2003, he held positions at GlaxoSmithKline as a medicinal chemist, project leader and department director. Since 2003, he has worked as an Associate Director in the Oncology iMed Chemistry Department of AstraZeneca. He has experience of working in CNS, inflammation, antiviral and oncology discovery and development chemistry. He currently leads AstraZeneca's Oncology lead identification chemistry group and is accountable for many of its discovery chemistry externalisation and project collaboration activities.

Dr David Andrews will be starting a one year part-time secondment from the UK Oncology Chemistry group to the Royal Society of Chemistry (RSC) in September. The Royal Society of Chemistry aims to support and accelerate innovation by bringing together academic, industrial, governmental and other partners to share knowledge, form strong networks and develop new skills. As part of this major commitment by the RSC to knowledge sharing and open innovation, it has created a senior Industry Associate role.

David will be supporting the RSC in defining an open innovation strategy and business plan for the Pharmaceutical Sector that drives the sustainable development of an open innovation environment to support researchers working in the field. His role will include leadership of the National Compound Collection initiative, providing strong and visible RSC sponsorship of the Strategic Advisory Group and ensuring a smooth transition from pilot phase to national scheme. Additionally, David will provide advice on user requirements for data and knowledge sharing as well as the development/acquisition of platforms that foster collaboration around data/knowledge, thus facilitating new cross-sector networks and partnerships.

Concurrent with his secondment, David will continue as a member of the Oncology iMed Chemistry Department, where he has been a member of the department leadership team since 2003. David is a Bachelor Pharmacy (BPharm) and PhD Chemist, and prior to AZ, worked at GSK from 1990-2003, latterly as Director of Virology Chemistry. David has a great knowledge and in-depth understanding of the external chemistry world and emerging open innovation models, and has authored papers and delivered external presentations on this topic.

The Royal Society of Chemistry is the world's leading chemistry community, advancing excellence in the chemical sciences. With 49,000 members and a knowledge business that spans the globe, the RSC is the UK's professional body for chemical scientists; a not-for-profit organisation with 170 years of history and an international vision for the future. The RSC promotes, supports and celebrates chemistry; it works to shape the future of the chemical sciences - for the benefit of science and humanity.